Multi-axis metabolic 3D modelling identifies a distinct phenotype in double negative demyelinating disease
This framework resolves overlapping and clinically ambiguous phenotypes, improves separation of progressive and seronegative cases, and reveals DN as a heterogeneous entity that is metabolically distinct from MS while demonstrating closer proximity to MOGAD.